Pharmaceuticals

Unlocking Solutions to Chronic Disease: Q&A with Bobby Azamian

bexib
By bexib 0 Min Read

The CEO of Tarsus Pharmaceuticals explains how the company is finding solutions that may have been overlooked before.

You Might Also Like

Regenxbio CEO to step down after 15 years

Eliminating maternal health disparities and driving change

Herantis Pharma awards €3.6 million to evaluate treatment for Parkinson’s disease

Lilly invests $1 billion in ‘biology first’ for obesity gene therapy

QuantaMatrix’s AMR inspection technology is backed by research paper in Nature magazine

Share This Article
Previous Article 5 Content Marketing Ideas for July 2024
Next Article Balancing for a soft landing
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Stay Connected

Latest News

Sri Lanka’s Ugauragara provides a memorable outdoor dining experience called “Ugauragara no Kamata”.
Hospitality & Tourism
FinTech financing: Datadirect Networks has $ 300 million
Banking
CFPB imposes a fine of $ 2.5 million in Fintech Wise
Banking
Within the city’s cloud migration strategy
Banking